Polymeric and Thiolated Nanopharmaceuticals: Advances in Drug Delivery and Therapeutic Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 10 June 2024 | Viewed by 174
Special Issue Editor
Interests: nanomaterials; colon cancer; drug delivery; polymeric materials; mucoadhesion; thiolation; pharmaceutical drug development; controlled drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue, entitled "Polymeric and Thiolated Nanopharmaceuticals: Advances in Drug Delivery and Therapeutic Applications", explores the cutting-edge innovations at the intersection of polymers, thiolated compounds, and nanopharmaceuticals. It delves into the forefront of drug delivery, presenting advanced formulations and strategies that have the potential to redefine therapeutic applications. From the design intricacies of polymeric carriers to the unique properties conferred by thiolation, it explores the potential of nanopharmaceuticals to revolutionize drug release mechanisms and enable targeted delivery. This Special Issue offers a comprehensive exploration of the latest breakthroughs, addressing challenges in drug delivery through novel formulations and controlled release techniques. It serves as a valuable resource for researchers and practitioners seeking a nuanced understanding of the evolving landscape of polymeric and thiolated nanopharmaceuticals. By providing a dedicated platform for researchers, this Special Issue aims to facilitate the exchange of knowledge on nanoparticle formulations, targeted drug delivery systems, nanomedicine, and nanotheranostics.
Dr. Sobia Noreen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- polymeric nanopharmaceuticals
- thiolated drug delivery
- nanomedicine
- nanotheranostics
- nanoparticle formulations
- targeted drug delivery
- nanotechnology in pharmacology
- therapeutic nanosystems
- pharmaceutical nanotechnology
- polymeric nanotechnology
